Nav: Home

Lymphoma Research Foundation and John Theurer Cancer Center host Ask the Doctor program

October 22, 2012

Hackensack, NJ (October 22, 2012) - The Lymphoma Research Foundation (LRF), the nation's largest non-profit organization devoted to lymphoma research, is partnering with John Theurer Cancer Center, one of the nation's 50 best hospitals for cancer, to bring the lymphoma community information about the rapidly changing world of lymphoma treatment. The educational program, titled Ask the Doctor About Lymphoma, will be held on Tuesday, October 23 at John Theurer Cancer Center in Hackensack, NJ.

"The Lymphoma Research Foundation's Ask the Doctor programs provide opportunities for attendees to hear from leading lymphoma researchers and clinicians, gaining a better understanding of the disease and the treatment options currently available," said Brian Tomlinson, LRF Chief Program Officer. "The Lymphoma Research Foundation looks forward to collaborating with Dr. Andre Goy of John Theurer Cancer Center to bring this important information to the New Jersey lymphoma community."

Ask the Doctor About Lymphoma programs provide the latest information about lymphoma and its treatments to local communities across the United States. The upcoming program in Hackensack, New Jersey will consist of a two-hour topic-specific seminar led by Andre Goy, M.D., M.S., Chairman and Director and Chief of Lymphoma, John Theurer Cancer Center. Dr. Goy is an internationally-recognized researcher who leads one of the largest lymphoma programs the country, and is also a member of the Lymphoma Research Foundation's Scientific Advisory Board. He will present a brief overview of lymphoma and discuss the latest treatment options and research. The presentation will be followed by a two-hour question and answer session.

"An impressive number of new options have emerged in the last few years in lymphoma, translating to better outcome for our patients"," said Dr. Goy. "This seminar is a great opportunity for patients and caregivers to gain a better understanding of lymphoma, a very diverse disease with evolving and changing treatment options, so they can become active participants in their care."

The program is offered free-of-charge to members of the lymphoma community, and dinner will be provided for all registered attendees; however, pre-registration is required. To register, visit lymphoma.org/askthedoctor or call 1-800-500-9976. This program is supported through an unrestricted grant from Spectrum Pharmaceuticals.

"Keeping patients informed about their disease is one of the key pillars of our program," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center. "Education can help reduce some of the fears that come with a cancer diagnosis by shedding light on what can be expected."
-end-
About John Theurer Cancer Center at Hackensack University Medical Center

John Theurer Cancer Center at Hackensack University is among the nation's top 50 U.S. News and World Report Best Hospitals for cancer - the highest-ranked in New Jersey with this designation. It is New Jersey's largest and most comprehensive cancer center dedicated to the diagnosis, treatment, management, research, screenings, preventive care, as well as survivorship of patients with all types of cancer.

Each year, more people in the New Jersey/New York metropolitan area turn to the John Theurer Cancer Center for cancer care than to any other facility in New Jersey. The 14 specialized divisions feature a team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. The John Theurer Cancer Center provides comprehensive multidisciplinary care, state of the art technology, access to clinical trials, compassionate care and medical expertise--all under one roof. For more information please visit jtcancercenter.org

About the Lymphoma Research Foundation

The Lymphoma Research Foundation (LRF) is the nation's largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $50 million in lymphoma-specific research.

For additional information on LRF's research, education and services, visit lymphoma.org.

John Theurer Cancer Center

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.